{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:22:13Z","timestamp":1792686133435,"version":"4.5.0"},"reference-count":20,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Atrial fibrillation (AF) is frequently observed in cancer patients, driven by mutual comorbidities and increasing the risk of thromboembolic events. Impediments can hinder the utilization of anticoagulants among patients with malignancy\u2014drug interactions with chemotherapy, renal dysfunction, drug intolerance, and increased bleeding risk. Left atrial appendage occlusion (LAAO) is an effective and safe non-pharmacological approach to prevent thromboembolic complications when anticoagulants are not suitable. Cancer patients were generally excluded from the original LAAO trials, and current safety and efficacy in cancer patients remain uncertain. Methods: This retrospective study utilized the National Inpatient Sample (NIS) database to analyze in-hospital outcomes of LAAO in US patients with and without cancer between 2016 and 2019. Patient demographics, comorbidities, procedures, and in-hospital outcomes were extracted using ICD-10-CM codes. Results: Among 12,273 hospitalizations for LAAO across the US representing an estimated 61,365 LAAO procedures, 2.2% (1365 cases) were performed in cancer patients. Older age, male gender, chronic kidney disease, prior stroke, and anemia were more prevalent in the cancer group, with 785 (58%) having a solid malignancy and 580 (42%) having a hematologic malignancy. Compared to non-cancer patients, cancer patients exhibited a higher rate of in-hospital complications (8.8% vs. 5.7%; p &lt; 0.001), primarily driven by acute kidney injury (4.4% vs. 2.4%; p = 0.002), acute heart failure (3.7% vs. 2.6%; p = 0.012), and cardiac tamponade (1.5% vs. 0.8%; p = 0.006). No significant differences were observed in vascular complications, periprocedural stroke, or in-hospital mortality. Average length of stay (LOS) was longer in cancer patients (1.4 \u00b1 2.7 days vs. 1.8 \u00b1 2.5 days; p &lt; 0.001). Conclusions: This nationwide study found that cancer patients undergoing LAAO had an increased rate of in-hospital complications, particularly acute kidney injury, heart failure, and tamponade, but no increase in in-hospital mortality was observed. Further research is needed to evaluate the long-term safety and efficacy of LAAO for managing embolic prevention in this complex patient population.<\/jats:p>","DOI":"10.3390\/cancers17081331","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:50:27Z","timestamp":1744699827000},"page":"1331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In-Hospital Outcomes of Left Atrial Appendage Occlusion Among Cancer Patients with Atrial Fibrillation: A Nationwide U.S. Study"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-2764","authenticated-orcid":false,"given":"Gilad","family":"Margolis","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"},{"name":"Cardiac Electrophysiology Unit, Hillel Yaffe Medical Center, Hadera 3810101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Vishnevskiy","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Folman","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kazatsker","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"},{"name":"Cardiac Electrophysiology Unit, Hillel Yaffe Medical Center, Hadera 3810101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Roguin","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8896-460X","authenticated-orcid":false,"given":"Eran","family":"Leshem","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 3109601, Israel"},{"name":"Cardiac Electrophysiology Unit, Hillel Yaffe Medical Center, Hadera 3810101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ehjqcco\/qcx004","article-title":"Management and outcomes of patients with atrial fibrillation and a history of cancer: The ORBIT-AF registry","volume":"3","author":"Melloni","year":"2017","journal-title":"Eur. Hear. J. Qual. Care Clin. Outcomes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: A scientific statement from the American heart association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Po\u00e9nou, G., Tol\u00e9dano, E., Helfer, H., Plaisance, L., Happe, F., Versini, E., Diab, N., Djennaoui, S., and Mah\u00e9, I. (2023). Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1132156"},{"key":"ref_4","first-page":"1341","article-title":"Anticoagulation Strategies in Patients With Cancer","volume":"73","author":"Mosarla","year":"2019","journal-title":"JACC Rev. Cardiovasc. Interv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"A344","DOI":"10.1016\/S0735-1097(15)60344-8","article-title":"The Myth of the Stable INR Patient: Results from ORBIT-AF","volume":"66","author":"Pokorney","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1634\/theoncologist.2017-0274","article-title":"Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis","volume":"23","author":"Lin","year":"2018","journal-title":"Oncologist"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.rpth.2023.100096","article-title":"Atrial fibrillation in cancer: Thromboembolism and bleeding in daily practice","volume":"7","author":"Chu","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Margolis, G., Goldhaber, O., Kazatsker, M., Kobo, O., Roguin, A., and Leshem, E. (2024). Atrial Fibrillation Catheter Ablation among Cancer Patients: Utilization Trends and In-Hospital Outcomes. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051318"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacep.2016.06.006","article-title":"Left Atrial Appendage: Embryology, Anatomy, Physiology, Arrhythmia and Therapeutic Intervention","volume":"2","author":"Naksuk","year":"2016","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL Trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_12","first-page":"203","article-title":"Left atrial appendage occlusion in patients with atrial fibrillation and cancer","volume":"5","author":"Shabtaie","year":"2023","journal-title":"J. Am. Coll. Cardiol. CardioOnc."},{"key":"ref_13","first-page":"299","article-title":"Outcomes of patients with cancer undergoing percutaneous left atrial appendage occlusion","volume":"68","author":"Agarwal","year":"2023","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2020.12.003","article-title":"Procedural and short-term outcomes of percutaneous left atrial appendage closure in patients with cancer","volume":"141","author":"Isogai","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_15","unstructured":"HCUP National Inpatient Sample (NIS) (2024, November 28). Agency for Healthcare Research and Quality, Available online: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref_16","first-page":"143","article-title":"The healthcare cost and utilization project: An overview","volume":"5","author":"Steiner","year":"2002","journal-title":"Eff. Clin. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","article-title":"Insights from the nationwide AMIS Plus registry 2002\u20132012","volume":"100","author":"Radovanovic","year":"2014","journal-title":"Heart"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_20","first-page":"101585","article-title":"Short- and long-term outcomes of percutaneous left atrial appendage occlusion in cancer patients","volume":"56","author":"Tinoco","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:14:52Z","timestamp":1760030092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17081331"],"URL":"https:\/\/doi.org\/10.3390\/cancers17081331","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}